Related Experiment Video
Updated: Jul 10, 2026

08:10
A Liquid Phase Affinity Capture Assay Using Magnetic Beads to Study Protein-Protein Interaction: The Poliovirus-Nanobody Example
Published on: May 29, 2012
12.0K
Virus-Glycan Interactions Studied by Solute NMR
Lorena Rudolph1, Alvaro Mallagaray2
1Institute of Chemistry and Metabolomics, University of Lübeck, Lübeck, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|August 1, 2025
Summary
Nuclear magnetic resonance (NMR) advances understanding of how viruses attach to host cells. This technique reveals crucial details about virus-glycan interactions, aiding the development of new antiviral strategies.
Area of Science:
- Biochemistry
- Structural Biology
- Virology
Background:
- Viral cell entry mechanisms are not fully understood.
- Carbohydrates (glycans) are key in viral attachment to host cells.
- Existing methods like crystallography and cryo-electron microscopy (cryoEM) have limitations in detailing virus-glycan recognition at atomic resolution.
Purpose of the Study:
- To provide an overview of nuclear magnetic resonance (NMR) applications in studying virus-glycan interactions.
- To highlight NMR's role in elucidating principles of viral entry.
- To explore the potential of NMR in developing novel antiviral strategies.
Main Methods:
- Overview of solute NMR techniques applied to native viruses, virus-like particles (VLPs), and viral subparticles.
- Ligand-based NMR for studying minimal structural requirements for glycan recognition under physiological conditions.
- Protein NMR for insights into protein-glycan binding, stability, and dynamics.
Main Results:
- Solute NMR provides atomic-level insights into virus-glycan recognition.
- Ligand-based NMR is effective for native viruses and VLPs.
- Protein NMR offers detailed information on binding, stability, and dynamics.
Conclusions:
- NMR is a powerful technique for understanding virus-glycan interactions.
- NMR-based studies can reveal critical aspects of viral entry.
- This research supports the development of antivirals targeting early infection stages by disrupting glycan recognition.

